Christopher S. Kollmann

1.4k total citations
9 papers, 360 citations indexed

About

Christopher S. Kollmann is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Christopher S. Kollmann has authored 9 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Virology and 4 papers in Molecular Biology. Recurrent topics in Christopher S. Kollmann's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Chemical Synthesis and Analysis (3 papers). Christopher S. Kollmann is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Chemical Synthesis and Analysis (3 papers). Christopher S. Kollmann collaborates with scholars based in United States and Canada. Christopher S. Kollmann's co-authors include Ting‐Chao Chou, Martin Hirsch, Françoise Giguel, Cécile Tremblay, Yongbiao Guan, Bahige M. Baroudy, David R. Lancia, Kevin Riehle, Martin M. Matzuk and John C. Faver and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Christopher S. Kollmann

8 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher S. Kollmann United States 7 188 170 164 76 75 9 360
Kazuki Izumi Japan 11 232 1.2× 204 1.2× 190 1.2× 51 0.7× 80 1.1× 20 411
Yasushi Tojo Japan 8 210 1.1× 197 1.2× 139 0.8× 43 0.6× 53 0.7× 9 372
Takuya Kobayakawa Japan 11 165 0.9× 180 1.1× 191 1.2× 24 0.3× 47 0.6× 44 378
Surya Sankuratri United States 12 239 1.3× 162 1.0× 138 0.8× 122 1.6× 150 2.0× 15 437
Brett S. Robinson United States 6 424 2.3× 445 2.6× 169 1.0× 36 0.5× 61 0.8× 9 633
Cajetan Dogo‐Isonagie United States 10 209 1.1× 130 0.8× 148 0.9× 74 1.0× 77 1.0× 16 454
Steven J. Hawrylik United States 7 234 1.2× 266 1.6× 301 1.8× 39 0.5× 31 0.4× 8 563
S.L. Irving United Kingdom 7 218 1.2× 186 1.1× 326 2.0× 48 0.6× 29 0.4× 8 547
Brian McAuliffe United States 9 301 1.6× 295 1.7× 61 0.4× 34 0.4× 56 0.7× 10 375
Felix Deanda United States 11 289 1.5× 321 1.9× 221 1.3× 25 0.3× 34 0.5× 13 487

Countries citing papers authored by Christopher S. Kollmann

Since Specialization
Citations

This map shows the geographic impact of Christopher S. Kollmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Kollmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Kollmann more than expected).

Fields of papers citing papers by Christopher S. Kollmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Kollmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Kollmann. The network helps show where Christopher S. Kollmann may publish in the future.

Co-authorship network of co-authors of Christopher S. Kollmann

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Kollmann. A scholar is included among the top collaborators of Christopher S. Kollmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Kollmann. Christopher S. Kollmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kollmann, Christopher S.. (2022). Quantitation of DNA-Encoded Libraries by qPCR. Methods in molecular biology. 2541. 135–142.
2.
Franklin, G. Joseph, et al.. (2020). The Impact of Variable Selection Coverage on Detection of Ligands from a DNA-Encoded Library Screen. SLAS DISCOVERY. 25(5). 515–522. 12 indexed citations
3.
Faver, John C., Kevin Riehle, David R. Lancia, et al.. (2019). Quantitative Comparison of Enrichment from DNA-Encoded Chemical Library Selections. ACS Combinatorial Science. 21(2). 75–82. 55 indexed citations
4.
Kollmann, Christopher S., Xiaopeng Bai, Hongfang Yang, et al.. (2014). Application of encoded library technology (ELT) to a protein–protein interaction target: Discovery of a potent class of integrin lymphocyte function-associated antigen 1 (LFA-1) antagonists. Bioorganic & Medicinal Chemistry. 22(7). 2353–2365. 71 indexed citations
5.
Tremblay, Cécile, Jennifer L. Hicks, Annie Chamberland, et al.. (2003). Favorable Interactions between Enfuvirtide and 1-β- d -2,6-Diaminopurine Dioxolane In Vitro. Antimicrobial Agents and Chemotherapy. 47(11). 3644–3646. 6 indexed citations
6.
Tremblay, Cécile, Françoise Giguel, Christopher S. Kollmann, et al.. (2002). Anti-Human Immunodeficiency Virus Interactions of SCH-C (SCH 351125), a CCR5 Antagonist, with Other Antiretroviral Agents In Vitro. Antimicrobial Agents and Chemotherapy. 46(5). 1336–1339. 70 indexed citations
7.
Kollmann, Christopher S., Cécile Tremblay, Françoise Giguel, Ting‐Chao Chou, & Martin Hirsch. (2001). In Vitro Anti-HIV-1 Synergy between Non-Nucleoside Reverse Transcriptase Inhibitors Nevirapine and Efavirenz. Antiviral Therapy. 6(2). 143–144. 7 indexed citations
8.
Kollmann, Christopher S., et al.. (2000). Strong in Vitro Synergy Between the Fusion Inhibitor T-20 and the CXCR4 Blocker AMD-3100. JAIDS Journal of Acquired Immune Deficiency Syndromes. 25(2). 99–102. 80 indexed citations
9.
Tremblay, Cécile, Christopher S. Kollmann, Françoise Giguel, Ting‐Chao Chou, & Martin Hirsch. (2000). Strong in Vitro Synergy Between the Fusion Inhibitor T-20 and the CXCR4 Blocker AMD-3100. JAIDS Journal of Acquired Immune Deficiency Syndromes. 25(2). 99–102. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuki Izumi Breakdown of academic impact, for papers by Yasushi Tojo Breakdown of academic impact, for papers by Takuya Kobayakawa Breakdown of academic impact, for papers by Surya Sankuratri Breakdown of academic impact, for papers by Brett S. Robinson Breakdown of academic impact, for papers by Cajetan Dogo‐Isonagie Breakdown of academic impact, for papers by Steven J. Hawrylik Breakdown of academic impact, for papers by S.L. Irving Breakdown of academic impact, for papers by Brian McAuliffe Breakdown of academic impact, for papers by Felix Deanda
Rankless by CCL
2026